Biomedical Sciences and Health | SRI International

Toggle Menu

SRI Blog: Biomedical Sciences and Health

Christopher Harris
Sep 27, 2016

If the new science standards could be summed up in one grand sentence, it would likely be – “It is not what you know, but how you use and apply what you know that makes a real difference for science learning."

Diane Beylkin
Aug 3, 2016

From its inception, SRI International was structured to encourage collaboration between scientists across disciplines. This approach has generated many groundbreaking discoveries and technologies over the years.

Jul 20, 2016

Collaboration is Key to Tackling Emerging Infectious Diseases

May 24, 2016

A New Approach to Fighting Flu

Feb 11, 2016

Combining Capabilities to Address the Zika Emergency

Rich Mahoney
Dec 10, 2015

Another transformational robotic technology from SRI is being brought to market.

Thomas Webb
Oct 5, 2015

An intricate and poorly understood molecular machine appears to have great promise as a new drug target class and is an Achilles’ heel for certain types of cancer. This molecular machine is called the spliceosome.

Aug 26, 2015

Researchers in SRI Biosciences’ infectious disease group are working to develop diagnostic tests, vaccines, and therapies that can help medical professionals around the world more effectively treat frightening and deadly illnesses.

Kathlynn Brown
Aug 14, 2015

My group at SRI Biosciences is driven by the idea of a “magic bullet” drug that can home in on a particular cell type and avoid healthy cells. This notion of a magic bullet has been around for 100 years, but finding molecules that recognize the address of a particular cell is challenging. In other...

Kathleen Hebbeler
May 27, 2015

The findings of our recently completed study show that there is a lot of room for improvement.

Peter Karp
Feb 11, 2015

Sequencing an organism’s genome is an important step in understanding how an organism functions. Learn about some of the latest advances.

Peter Karp
Dec 9, 2014

Researchers in a broad range of fields, from biotech to agriculture, use MetaCyc content to study organism pathways and metabolism. Its applications range from green chemicals to reducing climate change to improving human health to wine making.

David Sahner
Dec 4, 2014

SRI is particularly proud that this new facility—along with our productive collaboration with MEDC—will benefit a number of organizations and individuals as well as the greater community.

Sep 4, 2014

Learn how researchers in SRI Biosciences have identified a small molecule that looks like a promising therapy for psoriasis, an autoimmune disease of the skin affecting approximately two percent of the population.

David Sahner
Jun 12, 2014

SRI's newest facility will meet an important translational need for government and industry clients and partners, particularly small biotech companies that need early-stage human clinical trial services.

Ajay Divakaran
Jun 5, 2014

Our recent work in food recognition uses vision technology to record and quantify food items to help people make more informed eating decisions.

Lucia Beviglia
May 23, 2014

SRI Biosciences researchers have developed an advanced xenograft model for testing novel therapies. A lack of preclinical models that accurately mimic cancer and predict how well a compound may work in people is a key reason most cancer treatments fail during clinical development.

Lidia Sambucetti
Feb 19, 2014

For years, there has been a major unmet need for a more sensitive method for improved identification and characterization of rare circulating tumor cells (CTCs), blood markers that can identify tumors that are metastasizing and spreading.

Gita Shankar& Walter H. Moos
Nov 1, 2013

At SRI International, researchers are pursuing advances in antidotes and treatments such as oral medication that could be given to mass populations in the event of a disaster such as radiation exposure.

Stephen Morairty
Jul 26, 2013

Researchers in SRI's Center for Neuroscience are searching for a biomarker that could help diagnose neurodegenerative diseases years before symptoms appear and brain damage is already extensive.